FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shamir Mehta

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Akshay Bagai; Bjug Borgundvaag; Warren Cantor; Eric A Cohen; John Ducas; Vladimír Džavík; David Fitchett; Michael Heffernan; Andre Lamy; Anatoly Langer; Charles Lazzam; Shamir R Mehta; Laurie Morrison; Brian Schwartz; Mary Tan; Wesley Tong; Shaun G Goodman
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study.
Sanjit S Jolly; Shamir R Mehta; Madhu K Natarajan; Kari Niemela; Sunil V Rao; Tej Sheth; Philippe Gabriel STEG; Vicent Valentin; Petr Widimsky; Andrzej Budaj; John Cairns; Warren J Cantor; Asim N Cheema; Vladimír Džavík; Emile Ferrari; Anthony Fung; Peggy Gao; Barbara Jedrzejowski
Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial.
Victar Hsieh; Shamir R Mehta
How Should We Treat Multi-Vessel Disease in STEMI Patients?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shamir Mehta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Akshay Bagai; Bjug Borgundvaag; Warren Cantor; Eric A Cohen; John Ducas; Vladimír Džavík; David Fitchett; Michael Heffernan; Andre Lamy; Anatoly Langer; Charles Lazzam; Shamir R Mehta; Laurie Morrison; Brian Schwartz; Mary Tan; Wesley Tong; Shaun G Goodman
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study.
American heart journal 2013;165(4):630-637.e2.
2013: Sanjit S Jolly; Shamir R Mehta; Madhu K Natarajan; Kari Niemela; Sunil V Rao; Tej Sheth; Philippe Gabriel STEG; Vicent Valentin; Petr Widimsky; Andrzej Budaj; John Cairns; Warren J Cantor; Asim N Cheema; Vladimír Džavík; Emile Ferrari; Anthony Fung; Peggy Gao; Barbara Jedrzejowski
Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial.
JACC. Cardiovascular interventions 2013;6(3):258-66.
2013: Victar Hsieh; Shamir R Mehta
How Should We Treat Multi-Vessel Disease in STEMI Patients?
Current treatment options in cardiovascular medicine 2013;15(1):129-36.
2012: Shamir R Mehta; Kari Niemela; Sunil V Rao; Michael Rokoss; Philippe Gabriel STEG; Vicent Valentin; Salim Yusuf; Andrzej Budaj; John Cairns; Warren J Cantor; Asim N Cheema; Vladimír Džavík; Peggy Gao; Sanjit S Jolly
Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation.
Journal of the American College of Cardiology 2012;60(24):2490-9.
2012: Philippe Gabriel STEG; Stephen D Wiviott; Christoph Bode; Karen Fanouillere; Christophe Gaudin; Shamir R Mehta; Angele Moryusef; Charles V Pollack; Marc S Sabatine
Design and rationale of the treatment of acute coronary syndromes with otamixaban trial: a double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non-ST-segment elevation acute coronary syndromes with a planned early invasive strategy.
American heart journal 2012;164(6):817-24.e13.
2012: Shamir R Mehta; Jeffrey I Weitz
Warfarin after bioprosthetic aortic valve implantation.
JAMA : the journal of the American Medical Association 2012;308(20):2147-8.
2012: Vineet Bhan; Bjug Borgundvaag; Warren Cantor; Eric A Cohen; John Ducas; Vladimir Džavík; David Fitchett; Shaun G Goodman; Michael Heffernan; Shamir R Mehta; Laurie J Morrison; Raymond T Yan; Andrew T Yan
Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: a subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
American heart journal 2012;164(3):343-50.
2012: Deepak L Bhatt; Patrice Cacoub; Mark A Creager; John W Eikelboom; Eileen S Emison; Marcus D Flather; Keith A A Fox; Werner Hacke; Kandice Kottke-Marchant; A Michael Lincoff; Koon-Hou Mak; Shamir R Mehta; Gilles Montalescot; Gurunathan Murugesan; Guillaume Paré; Katy L Simonsen; Ph Gabriel Steg; Steven R Steinhubl; Eric J Topol; Peter B Berger; Nihar Bhakta
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study.
European heart journal 2012;33(17):2143-50.
2012: Guillaume Paré; Stephanie Ross; Salim Yusuf; Sonia S Anand; Stuart J Connolly; Keith A A Fox; Shamir R Mehta; John W Eikelboom
Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events.
Circulation. Cardiovascular genetics 2012;5(2):250-6.
2012: Kara A Nerenberg; Jennifer Ng; Alben Sigamani; Denis Xavier; Salim Yusuf; Rafael Díaz; Hertzel C Gerstein; Abhinav Goyal; Mikhail Kosiborod; Shamir R Mehta
Piloting a novel algorithm for glucose control in the coronary care unit: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial.
Diabetes care 2012;35(1):19-24.
2011: Ph Gabriel Steg; Alberto Garcia-Hernandez; C Michael Gibson; Christopher B Granger; J Wouter Jukema; Petr Kala; Frantisek Kovar; Gregory Y H Lip; Shamir R Mehta; Ronny W Renfurm
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.
European heart journal 2011;32(20):2541-54.
2011: Daniel J Quinlan; Pierre Théroux; Robert C Welsh; John W Eikelboom; David H Fitchett; Shaun G Goodman; Shamir R Mehta
Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes.
European heart journal 2011;32(18):2256-65.
2011: Kevin R Bainey; T F Lai; Shamir R Mehta
Clopidogrel in acute coronary syndromes: where are we now?
Thrombosis and haemostasis 2011;105(5):766-73.
2011: Sanjit S Jolly; Salim Yusuf; John Cairns; Kari Niemelä; Denis Xavier; Petr Widimsky; Andrzej Budaj; Matti Niemelä; Vicent Valentin; Basil S. Lewis; Alvaro Avezum; Philippe Gabriel STEG; Sunil V Rao; Peggy Gao; Rizwan Afzal; Campbell D Joyner; Susan Chrolavicius; Shamir R Mehta
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.
Lancet 2011;377(9775):1409-20.
2011: Sanjit S Jolly; Kari Niemelä; Denis Xavier; Petr Widimsky; Andrzej Budaj; Vicent Valentin; Basil S. Lewis; Alvaro Avezum; Philippe Gabriel STEG; Sunil V Rao; John Cairns; Susan Chrolavicius; Salim Yusuf; Shamir R Mehta
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes.
American heart journal 2011;161(2):254-260.e1-4.
2010: Tjeerd E van Rees Vellinga; Ron J G Peters; Salim Yusuf; Rizwan Afzal; Susan Chrolavicius; Martin O'Donnell; Shamir R Mehta; Wadysław Pluta; Jerzy Sacha; John W Eikelboom
Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial.
American heart journal 2010;160(6):1049-55.
2010: Guillaume Paré; Shamir R Mehta; Salim Yusuf; Sonia S Anand; Stuart J Connolly; Jack Hirsh; Katy Simonsen; Deepak L Bhatt; Keith A A Fox; John W Eikelboom
Effects of CYP2C19 genotype on outcomes of clopidogrel treatment.
The New England journal of medicine 2010;363(18):1704-14.
2010: Shamir R Mehta; Jean-Francois Tanguay; John W Eikelboom; Sanjit S Jolly; Campbell D Joyner; Christopher B Granger; David P Faxon; Hans-Jurgen Rupprecht; Andrzej Budaj; Alvaro Avezum; Petr Widimsky; Philippe Gabriel STEG; Jean-Pierre Bassand; Gilles Montalescot; Carlos Macaya; Giuseppe Di Pasquale; Kari Niemela; Andrew E Ajani; Harvey D White; Susan Chrolavicius; Peggy Gao; Keith A A Fox; Salim Yusuf
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
Lancet 2010;376(9748):1233-43.
2010: Philippe Gabriel STEG; Sanjit S Jolly; Shamir R Mehta; Rizwan Afzal; Denis Xavier; Hans-Jurgen Rupprecht; Jose L López-Sendón; Andrzej Budaj; Rafael Diaz; Alvaro Avezum; Petr Widimsky; Sunil V Rao; Susan Chrolavicius; Brandi Meeks; Campbell Joyner; Janice Pogue; Salim Yusuf
Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.
JAMA : the journal of the American Medical Association 2010;304(12):1339-49.
2010: Kevin R Bainey; Shamir R Mehta
Aspirin for acute coronary syndromes: have we learned the correct dose yet?
Current cardiology reports 2010;12(4):344-7.
2010: Jeremy S Paikin; Douglas S Wright; Mark A Crowther; Shamir R Mehta; John W Eikelboom
Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.
Circulation 2010;121(18):2067-70.
2010: Jeremy S Paikin; Shamir R Mehta; John W Eikelboom
Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.
The Medical journal of Australia 2010;192(9):487-8.
2009: Abhinav Goyal; Shamir R Mehta; Rafael Díaz; Hertzel C Gerstein; Rizwan Afzal; Denis Xavier; Lisheng Liu; Prem Pais; Salim Yusuf
Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction.
Circulation 2009;120(24):2429-37.
2009: Behnam Banihashemi; Shaun G Goodman; Raymond T Yan; Robert C Welsh; Shamir R Mehta; Gilles Montalescot; Jan M Kornder; Graham C Wong; Gabor Gyenes; Ph Gabriel Steg; Andrew T Yan
Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience.
American heart journal 2009;158(6):917-24.
2009: Jeffrey S Berger; Deepak L Bhatt; Christopher P Cannon; Zhengming Chen; Lixin Jiang; James B Jones; Shamir R Mehta; Marc S Sabatine; Steven R Steinhubl; Eric J Topol; Peter B Berger
The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis.
Journal of the American College of Cardiology 2009;54(21):1935-45.
2009: Sanjit S Jolly; David P Faxon; Keith A A Fox; Rizwan Afzal; William E Boden; Petr Widimsky; Philippe Gabriel STEG; Vicent Valentin; Andrzej Budaj; Christopher B Granger; Campbell D Joyner; Susan Chrolavicius; Salim Yusuf; Shamir R Mehta
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial.
Journal of the American College of Cardiology 2009;54(5):468-76.
2009: charan lanjewar; Sanjit Jolly; Shamir R Mehta
Effects of aspiration thrombectomy on mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of the randomized trials.
Indian heart journal 2009;61(4):335-40.
2009: Warren J Cantor; David Fitchett; Bjug Borgundvaag; John Ducas; Michael Heffernan; Eric A Cohen; Laurie J Morrison; Anatoly Langer; Vladimir Dzavik; Shamir R Mehta; Charles Lazzam; Brian Schwartz; Amparo Casanova; Shaun G Goodman
Routine early angioplasty after fibrinolysis for acute myocardial infarction.
The New England journal of medicine 2009;360(26):2705-18.
2009: Shamir R Mehta; Christopher B Granger; William E Boden; Philippe Gabriel STEG; Jean-Pierre Bassand; David P Faxon; Rizwan Afzal; Susan Chrolavicius; Sanjit S Jolly; Petr Widimsky; Alvaro Avezum; Hans-Jurgen Rupprecht; Jun Zhu; Jacques Col; Madhu K Natarajan; Craig Horsman; Keith A A Fox; Salim Yusuf
Early versus delayed invasive intervention in acute coronary syndromes.
The New England journal of medicine 2009;360(21):2165-75.
2009: Mark J Sculpher; Greta Lozano-Ortega; Jennifer Sambrook; Stephen Palmer; Orges Ormanidhi; Ameet Bakhai; Marcus Flather; Philippe Gabriel STEG; Shamir R Mehta; William Weintraub
Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.
American heart journal 2009;157(5):845-52.
2009: Abhinav Goyal; Shamir R Mehta; Hertzel C Gerstein; Rafael Díaz; Rizwan Afzal; Denis Xavier; Jun Zhu; Prem Pais; Liu Lisheng; Khawar A Kazmi; Mohammad Zubaid; Leopoldo S Piegas; Petr Widimsky; Andrzej Budaj; Alvaro Avezum; Salim Yusuf
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction.
American heart journal 2009;157(4):763-70.
2009: Sanjit S Jolly; Janice Pogue; Kimberly Haladyn; Ron J G Peters; Keith A A Fox; Alvaro Avezum; Bernard J Gersh; Hans Jurgen Rupprecht; Salim Yusuf; Shamir R Mehta
Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.
European heart journal 2009;30(8):900-7.
2009: Shamir R Mehta
Aspirin for prevention and treatment of cardiovascular disease.
Annals of internal medicine 2009;150(6):414-6.
2009: Ganesan Karthikeyan; Shamir R Mehta; John W Eikelboom
Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6.
Expert review of cardiovascular therapy 2009;7(3):241-9.
2009: Campbell D Joyner; Ron J G Peters; Rizwan Afzal; Susan Chrolavicius; Shamir R Mehta; Keith A A Fox; Christopher B Granger; Maria Grazia Franzosi; Marcus Flather; Andrzej Budaj; Jean-Pierre Bassand; Salim Yusuf
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk.
American heart journal 2009;157(3):502-8.
2009: Andrzej Budaj; John W Eikelboom; Shamir R Mehta; Rizwan Afzal; Susan Chrolavicius; Jean-Pierre Bassand; Keith A A Fox; Lars Wallentin; Ron J G Peters; Christopher B Granger; Campbell D Joyner; Salim Yusuf
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes.
European heart journal 2009;30(6):655-61.
2008: Shamir R Mehta; Jean-Pierre Bassand; Susan Chrolavicius; Rafael Diaz; Keith A A Fox; Christopher B Granger; Sanjit Jolly; Hans-Jurgen Rupprecht; Petr Widimsky; Salim Yusuf
Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.
American heart journal 2008;156(6):1080-1088.e1.
2008: Shamir R Mehta; William E Boden; John W Eikelboom; Marcus Flather; Philippe Gabriel STEG; Alvaro Avezum; Rizwan Afzal; Leopoldo Soares Piegas; David P Faxon; Petr Widimsky; Andrzej Budaj; Susan Chrolavicius; Hans-Jurgen Rupprecht; Sanjit Jolly; Christopher B Granger; Keith A A Fox; Jean-Pierre Bassand; Salim Yusuf
Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
Circulation 2008;118(20):2038-46.
2008: Marc S Sabatine; Hussam N Hamdalla; Shamir R Mehta; Keith A A Fox; Eric J Topol; Steven R Steinhubl; Christopher P Cannon
Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use.
American heart journal 2008;155(5):910-7.
2008: Ron J G Peters; Campbell Joyner; Jean-Pierre Bassand; Rizwan Afzal; Susan Chrolavicius; Shamir R Mehta; Jonas Oldgren; Lars Wallentin; Andrzej Budaj; Keith A A Fox; Salim Yusuf
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial.
European heart journal 2008;29(3):324-31.
2008: Jonas Oldgren; Lars Wallentin; Rizwan Afzal; Jean-Pierre Bassand; Andrzej Budaj; Susan Chrolavicius; Keith A A Fox; Christopher B Granger; Shamir R Mehta; Prem Pais; Ron J G Peters; Denis Xavier; Jun Zhu; Salim Yusuf
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment.
European heart journal 2008;29(3):315-23.
2007: Rafael Díaz; Abhinav Goyal; Shamir R Mehta; Rizwan Afzal; Denis Xavier; Prem Pais; Susan Chrolavicius; Jun Zhu; Khawar Kazmi; Lisheng Liu; Andrzej Budaj; Mohammad Zubaid; Alvaro Avezum; Mikhail Ruda; Salim Yusuf
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
JAMA : the journal of the American Medical Association 2007;298(20):2399-405.
2007: Paul Kolm; Yong Yuan; Emir Veledar; Shamir R Mehta; Judith A O'Brien; William S Weintraub
Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trial.
The Canadian journal of cardiology 2007;23(13):1037-42.
2007: Shamir R Mehta; Christopher B Granger; John W Eikelboom; Jean-Pierre Bassand; Lars Wallentin; David P Faxon; Ron J G Peters; Andrzej Budaj; Rizwan Afzal; Susan Chrolavicius; Keith A A Fox; Salim Yusuf
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.
Journal of the American College of Cardiology 2007;50(18):1742-51.
2007: Keith A A Fox; Jean-Pierre Bassand; Shamir R Mehta; Lars Wallentin; Pierre Theroux; Leopoldo Soares Piegas; Vicent Valentin; Tiziano Moccetti; Susan Chrolavicius; Rizwan Afzal; Salim Yusuf
Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes.
Annals of internal medicine 2007;147(5):304-10.
2007: Mátyás Keltai; Marcello Tonelli; Johannes F E Mann; Eva Sitkei; Basil S. Lewis; Steven Hawken; Shamir R Mehta; Salim Yusuf
Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2007;14(2):312-8.
2006: John W Eikelboom; Shamir R Mehta; Sonia S Anand; Changchun Xie; Keith A A Fox; Salim Yusuf
Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.
Circulation 2006;114(8):774-82.
2006: Salim Yusuf; Shamir R Mehta; Susan Chrolavicius; Rizwan Afzal; Janice Pogue; Christopher B Granger; Andrzej Budaj; Ron J G Peters; Jean-Pierre Bassand; Lars Wallentin; Campbell Joyner; Keith A A Fox
Comparison of fondaparinux and enoxaparin in acute coronary syndromes.
The New England journal of medicine 2006;354(14):1464-76.
2006: Salim Yusuf; Shamir R Mehta; Susan Chrolavicius; Rizwan Afzal; Janice Pogue; Christopher B Granger; Andrzej Budaj; Ron J G Peters; Jean-Pierre Bassand; Lars Wallentin; Campbell Joyner; Keith A A Fox
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.
JAMA : the journal of the American Medical Association 2006;295(13):1519-30.
2006: Huyen Tran; Shamir R Mehta; John W Eikelboom
Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI).
Vascular health and risk management 2006;2(4):379-87.
2006: Madhu K Natarajan; James L Velianou; Alexander G G Turpie; Shamir R Mehta; Dominic Raco; David M Goodhart; Rizwan Afzal; Jeffrey S Ginsberg
A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions.
American heart journal 2006;151(1):175.
2005: John W Eikelboom; Daniel J Quinlan; Shamir R Mehta; Alexander G G Turpie; Ian B Menown; Salim Yusuf
Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
Circulation 2005;112(25):3855-67.
2005: Basil S. Lewis; Shamir R Mehta; Keith A A Fox; David A Halon; Feng Zhao; Ron J G Peters; Mátyás Keltai; Andrzej Budaj; Salim Yusuf
Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
American heart journal 2005;150(6):1177-84.
2005: Shamir R Mehta; Salim Yusuf; Christopher B Granger; Lars Wallentin; Ron J G Peters; Jean-Pierre Bassand; Andrzej Budaj; Campbell Joyner; Susan Chrolavicius; Keith A A Fox
Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes.
American heart journal 2005;150(6):1107.
2005: Christopher P Cannon; Shamir R Mehta; Sary F Aranki
Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery.
The Annals of thoracic surgery 2005;80(2):768-79.
2005: Shamir R Mehta; Christopher P Cannon; Keith A A Fox; Lars Wallentin; William E Boden; Rudolf Spacek; Petr Widimsky; Peter A McCullough; David Hunt; Eugene Braunwald; Salim Yusuf
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.
JAMA : the journal of the American Medical Association 2005;293(23):2908-17.
2005: Shamir R Mehta; Philippe Gabriel STEG; Christopher B Granger; Jean-Pierre Bassand; David P Faxon; Jeffrey I Weitz; Rizwan Afzal; Bonnie Rush; Ron J G Peters; Madhu K Natarajan; James L Velianou; David M Goodhart; Marino Labinaz; Jean-Francois Tanguay; Keith A A Fox; Salim Yusuf
Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.
Circulation 2005;111(11):1390-7.
2005: Shamir R Mehta; Salim Yusuf; Rafael Díaz; Jun Zhu; Prem Pais; Denis Xavier; Ernesto Andres Cesar Paolasso; Rashid Ahmed; Changchun Xie; Khawar Kazmi; Javed Tai; Andrés Orlandini; Janice Pogue; Lisheng Liu
Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;293(4):437-46.
2005: Salim Yusuf; Shamir R Mehta; Changchun Xie; Rashid J Ahmed; Denis Xavier; Prem Pais; Jun Zhu; Lisheng Liu
Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.
JAMA : the journal of the American Medical Association 2005;293(4):427-35.
2005: John W Eikelboom; Mark Feldman; Shamir R Mehta; Alan D Michelson; John A Oates; Eric J Topol
Aspirin resistance and its implications in clinical practice.
MedGenMed : Medscape general medicine 2005;7(3):76.
2005: Shamir R Mehta; John W Eikelboom; Catherine Demers; Aldo P Maggioni; Patrick J Commerford; Salim Yusuf
Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes.
Canadian journal of physiology and pharmacology 2005;83(1):98-103.
2004: Salim Yusuf; Shamir R Mehta; Rafael Díaz; Ernesto Andres Cesar Paolasso; Prem Pais; Denis Xavier; Changchun Xie; Rashid J Ahmed; Khawar Khazmi; Jun Zhu; Lisheng Liu
Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction.
American heart journal 2004;148(6):1068-78.
2004: Keith A A Fox; Shamir R Mehta; Ron Peters; Feng Zhao; Nasser Lakkis; Bernard J Gersh; Salim Yusuf
Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Circulation 2004;110(10):1202-8.
2004: Madhu K Natarajan; Catherine Kreatsoulas; James L Velianou; Shamir R Mehta; Dan Pericak; David M Goodhart
Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions.
The American journal of cardiology 2004;93(6):750-3.
2003: Ron J G Peters; Shamir R Mehta; Keith A A Fox; Feng Zhao; Basil S. Lewis; Steven L Kopecky; Rafael Diaz; Patrick J Commerford; Vicent Valentin; Salim Yusuf
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Circulation 2003;108(14):1682-7.
2003: Shamir R Mehta
Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.
The Journal of invasive cardiology 2003;15 Suppl B():17B-20B; discussion 20B-21B.
2003: Salim Yusuf; Shamir R Mehta; Feng Zhao; Bernard J Gersh; Patrick J Commerford; Mel Blumenthal; Andrzej Budaj; Thomas Wittlinger; Keith A A Fox
Early and late effects of clopidogrel in patients with acute coronary syndromes.
Circulation 2003;107(7):966-72.
2003: Shamir R Mehta; Salim Yusuf
Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
Journal of the American College of Cardiology 2003;41(4 Suppl S):79S-88S.
2002: Shamir R Mehta
Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
The Journal of invasive cardiology 2002;14 Suppl E():27E-34E; quiz 35E.
2002: Madhu K Natarajan; Shamir R Mehta; Douglas H Holder; David R Goodhart; Amiram Gafni; Donald Shilton; Rizwan Afzal; Koon Teo; Salim Yusuf
The risks of waiting for cardiac catheterization: a prospective study.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;167(11):1233-40.
2002: Andrzej Budaj; Salim Yusuf; Shamir R Mehta; Keith A A Fox; Gianni Tognoni; Feng Zhao; Susan Chrolavicius; David Hunt; Mátyás Keltai; Maria Grazia Franzosi
Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups.
Circulation 2002;106(13):1622-6.
2002: Shamir R Mehta; John W Eikelboom; H-J Rupprecht; Basil S. Lewis; Madhu K Natarajan; C Yi; Janice Pogue; Salim Yusuf
Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention.
European heart journal 2002;23(2):117-23.
2001: Shamir R Mehta; Salim Yusuf; Ron J G Peters; M E Bertrand; Basil S. Lewis; Madhu K Natarajan; Klas Malmberg; H Rupprecht; Feng Zhao; Susan Chrolavicius; I Copland; Keith A A Fox
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
Lancet 2001;358(9281):527-33.
2001: Salim Yusuf; Feng Zhao; Shamir R Mehta; Susan Chrolavicius; Gianni Tognoni; K K Fox
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
The New England journal of medicine 2001;345(7):494-502.
2001: L Cronin; Shamir R Mehta; Feng Zhao; Janice Pogue; Andrzej Budaj; David Hunt; Salim Yusuf
Stroke in relation to cardiac procedures in patients with non-ST-elevation acute coronary syndrome: a study involving >18 000 patients.
Circulation 2001;104(3):269-74.
2001: John W Eikelboom; Sonia S Anand; Shamir R Mehta; Jeffrey I Weitz; C Yi; Salim Yusuf
Prognostic significance of thrombocytopenia during hirudin and heparin therapy in acute coronary syndrome without ST elevation: Organization to Assess Strategies for Ischemic Syndromes (OASIS-2)study.
Circulation 2001;103(5):643-50.
2001: John W Eikelboom; Shamir R Mehta; Janice Pogue; Salim Yusuf
Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials: Intracranial hemorrhage in trials of bolus thrombolytic therapy.
JAMA : the journal of the American Medical Association 2001;285(4):444-50.
2001: Shamir R Mehta; John W Eikelboom; M K Natarajan; R Diaz; C Yi; R J Gibbons; Salim Yusuf
Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction.
Journal of the American College of Cardiology 2001;37(1):37-43.
2000: Shamir R Mehta; John W Eikelboom; Salim Yusuf
Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis.
Lancet 2000;356(9228):449-54.